Cytoki Pharma ApS, a private biotech company incorporated in Copenhagen, Denmark, today announced a $45 million series A financing led by existing investor Lundbeckfonden Emerge (Denmark) together ...
Read moreYsios Capital, Spain’s largest and leading European venture capital firm specialised in the biotechnology sector, announces today that it has closed its third fund, Ysios BioFund III (YBF III) at...
Read moreYsios Capital, a leading Spanish biotechnology venture capital firm, today announced that its portfolio company CVRx Inc. has priced its initial public offering (IPO) and is trading on the Nasdaq Glob...
Read more Corify Care is developing ACORYS®, a non-invasive cardiac mapping medical device to transform the cardiac arrhythmia treatment process.
Read moreNuage Therapeutics has announced the closing of a financing round by Sabadell Asabys, the investment vehicle managed by Asabys Partners. With this injection of capital, the spin-off will start its w...
Read moreFor the first time since its foundation, EIT Health offers the first pan-European crowdfunding platform dedicated exclusively to the healthcare sector. T
Read moreCarlos Rodríguez-Villa, General Manager of AlgaEnergy, will participate in the panel ‘The rise of Corporate Venture Capital (CVC) in Europe
Read moreSe trata de una compañía tecnológica impulsada por el Barcelonaβeta Brain Research Center (BBRC) en conjunto con los investigaodres Dr. Juan Domingo Gispert y Dr. José Luis Molinuevo.
Read moreVifor Pharma and Sanifit Therapeutics, a clinical-stage cardio-renal biopharmaceutical company focused on treatments for progressive vascular calcification disorders, today announced the companies hav...
Read moreEl proyecto «Early molecular nanoDIAGnostics of Brain tumors using ImmunePET (DIAGBI)» recibirá más de 1,4 millones de euros de financiación entre 2021 y 2024 dentro de la convocatoria de Proy...
Read morePalobiofarma has received the approval of the European project that finances Phase II of the PBF-680 product in COPD. Additionally, it offers the possibility of partial financing of Phase III of PBF-6...
Read morePeptomyc, the spin-off of the Vall d’Hebron Institute of Oncology (VHIO) and ICREA, and a member of CataloniaBio & HealthTech, has secured 8.6 million euros in funding from its current partners thro...
Read more